Skip to content

Public FDA record

Z-0771-2020: NIDEK Specular Microscope, Model CEM-530 - Product Usage: The device provides noncontact, high magnificat

Recall record Z-0771-2020 for Nidek, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0771-2020
Company in FDA record
Nidek, Inc.
FDA record creation date
Jan 2, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

The electromagnetic noise exceeded the upper limit of the Electromagnetic Compatibility Standard (EMC: IEC 60601-1-2)

Source facts

Action
The recalling firm issued letters dated 2/7/2019 via FedEx explaining the issue, informing the consignee there was no risk associated with use of the device, and that the firm is preparing for the replacement parts in order to schedule for the correction to be made.
Initiated
2019-02-25
Root cause
Device Design
Terminated
2021-06-15
Distribution
US Nationwide distribution in the states of AZ, CA, IL, KS, MD, NJ, NY, PA, SC, and VA, as well as PR.
Recall number
Z-0771-2020
Recall status
Terminated
CDRH record ID
177217
FDA record created
2020-01-02
Recall event number
84112

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗